Bloomberg News

Mazor Rises to Highest Level in 3 Weeks on Regulatory Approval

June 13, 2012

Mazor Robotics Ltd. (MZOR) advanced to the highest level in three weeks after receiving regulatory approval to market its Renaissance spinal surgery guidance system in South Korea.

The shares advanced 5.4 percent in intraday trading to 4.211 shekels, the highest level since May 20, as of 10:50 a.m. in Tel Aviv.

To contact the reporter on this story: David Wainer in Tel Aviv at dwainer3@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net


Coke's Big Fat Problem
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus